Skip to main content
MGNX logo
MGNX
(NASDAQ)
MacroGenics, Inc.
$4.40-- (--)
Loading... - Market loading

MacroGenics (MGNX) Stock Price & Financial Analysis

MacroGenics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.18 - $4.49
52-Week High$5.08
52-Week Low$1.29
Open$4.20
Volume442.51K
Average Volume (3M)511.68K
Market Cap279.18M
Shares Outstanding63.45M
Price to Sales (P/S)1.78
Price to Book (P/B)13.17
EV/EBITDA-4.92
Revenue (TTM)157.08M
Net Income (TTM)-70.36M
Free Cash Flow (TTM)-71.69M
EPS (TTM)$-1.11
Profit Margin-44.79%
Operating Margin-40.53%
Return on Equity (ROE)-331.91%
Debt to Equity1.72
50-Day MA$4.20
200-Day MA$3.02
52-Week Change120.00%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MacroGenics

What is the current stock price for MGNX?

As of the latest trading session, MGNX stock trades at $4.40. The 52-week range is $1.29–$5.08, with a day range of $4.17–$4.49.

What is the P/E ratio for MGNX?

The P/E ratio (Price-to-Earnings) for MGNX is shown in the Key Statistics section. This valuation metric helps compare MacroGenics, Inc. to industry peers.

Does MGNX pay dividends?

MacroGenics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MGNX?

Analyst ratings and recommendations for MGNX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MGNX?

MacroGenics's market capitalization is $279.2M, classifying it as a micro-cap company. MacroGenics operates in the Healthcare sector within the Biotechnology industry.